News Analysis

Most Recent

L'Oreal and UNESCO recognize exceptional women in science

By | March 8, 2002

L'Oreal and UNESCO have honored 16 women for their outstanding contributions to science.

0 Comments

US cloning debate gathers steam

By | March 7, 2002

US Senate debates bill aimed at banning both therapeutic and reproductive cloning.

0 Comments

Human stem cell research gets green light

By | March 5, 2002

The first UK licenses for human embryonic stem cell research have been granted.

0 Comments

Nanny state seeks new manacles

By | March 5, 2002

UK researchers fear that legislation debated on Monday in the House of Lords could infringe academic freedom.

0 Comments

French revolution

By | February 28, 2002

Plans to elevate the status of France's biotechnology sector have won support from within the industry.

0 Comments

Public consultation needed on xenotransplants

By | February 22, 2002

A session on xenotransplantation at the AAAS this week highlighted the need for urgent public consultation.

0 Comments

Yeast genome should provide insights to human disease

By | February 21, 2002

The fission yeast genome contains 50 genes with similarity to genes involved in human diseases.

0 Comments

A new initiative aims to establish a global network to increase access to academic and research publications.

0 Comments

Anthrax attacks highlight holes in US public health system

By | November 22, 2001

The bioterrorist activity in the United States has identified significant gaps in the supposed seamless and coherent response to major public health emergencies.

0 Comments

The multifunctional hairless gene

By | October 30, 2001

gene is capable of regulating its own expression, and that of other genes.

0 Comments

Advertisement
TECA Corporation
TECA Corporation

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Shimadzu Scientific
Shimadzu Scientific
Advertisement
The Scientist